Dayong Si

725 total citations
22 papers, 571 citations indexed

About

Dayong Si is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Dayong Si has authored 22 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Dayong Si's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Inflammatory mediators and NSAID effects (5 papers). Dayong Si is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Inflammatory mediators and NSAID effects (5 papers). Dayong Si collaborates with scholars based in China, Japan and New Zealand. Dayong Si's co-authors include Hui Zhou, Yingjie Guo, Dafang Zhong, Xiaoyan Chen, J. Paul Fawcett, Juan Wang, Ying Wang, Yingjie Guo, Ze‐Sheng Li and Dafang Zhong and has published in prestigious journals such as Applied and Environmental Microbiology, Applied Microbiology and Biotechnology and RSC Advances.

In The Last Decade

Dayong Si

22 papers receiving 562 citations

Peers

Dayong Si
Chitra Sridar United States
Stephanie D. Turner United States
Daniel R. Mudra United States
Claire Belloc France
Brian R. Baer United States
Mika Kurkela Finland
Bok-Ryang Kim South Korea
Susumu Imaoka Japan
Martine Bourrié France
Marc Bertrand France
Chitra Sridar United States
Dayong Si
Citations per year, relative to Dayong Si Dayong Si (= 1×) peers Chitra Sridar

Countries citing papers authored by Dayong Si

Since Specialization
Citations

This map shows the geographic impact of Dayong Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayong Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayong Si more than expected).

Fields of papers citing papers by Dayong Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayong Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayong Si. The network helps show where Dayong Si may publish in the future.

Co-authorship network of co-authors of Dayong Si

This figure shows the co-authorship network connecting the top 25 collaborators of Dayong Si. A scholar is included among the top collaborators of Dayong Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayong Si. Dayong Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wei, Yana Wang, Dayong Si, et al.. (2025). Do compression garments enhance running performance? An updated systematic review and meta-analysis. Journal of sport and health science. 14. 101028–101028. 1 indexed citations
2.
3.
Sun, Qian, Aiping Mao, Jie Li, et al.. (2025). Targeted long-read sequencing enables higher diagnostic yield of ADPKD by accurate PKD1 genetic analysis. npj Genomic Medicine. 10(1). 22–22. 1 indexed citations
4.
Takeuchi, Michiki, et al.. (2024). Gene identification and enzymatic characterization of the initial enzyme in pyrimidine oxidative metabolism, uracil-thymine dehydrogenase. Journal of Bioscience and Bioengineering. 137(6). 413–419. 2 indexed citations
5.
6.
Si, Dayong, et al.. (2014). Association of Common Polymorphisms in β1-adrenergic Receptor With Antihypertensive Response to Carvedilol. Journal of Cardiovascular Pharmacology. 64(4). 306–309. 21 indexed citations
7.
Zhang, Mingqiu, Chen Jia, Dayong Si, et al.. (2014). Whole exome sequencing identifies a novel EMDmutation in a Chinese family with dilated cardiomyopathy. BMC Medical Genetics. 15(1). 77–77. 19 indexed citations
8.
Poole, Anthony M., Ryan Catchpole, Dayong Si, et al.. (2014). The Case for an Early Biological Origin of DNA. Journal of Molecular Evolution. 79(5-6). 204–212. 18 indexed citations
9.
Si, Dayong, et al.. (2012). l-Pantoyl lactone dehydrogenase from Rhodococcus erythropolis: genetic analyses and application to the stereospecific oxidation of l-pantoyl lactone. Applied Microbiology and Biotechnology. 95(2). 431–440. 9 indexed citations
10.
Si, Dayong, et al.. (2012). LplR, a Repressor Belonging to the TetR Family, Regulates Expression of the l -Pantoyl Lactone Dehydrogenase Gene in Rhodococcus erythropolis. Applied and Environmental Microbiology. 78(22). 7923–7930. 5 indexed citations
11.
Si, Dayong, et al.. (2011). Cloning and overexpression of ketopantoic acid reductase gene from Stenotrophomonas maltophilia and its application to stereospecific production of d-pantoic acid. Applied Microbiology and Biotechnology. 93(4). 1619–1625. 9 indexed citations
12.
Zhang, Xianwei, Qian Deng, Dayong Si, et al.. (2011). Two NovelSCN9AGene Heterozygous Mutations May Cause Partial Deletion of Pain Perception. Pain Medicine. 12(10). 1510–1514. 19 indexed citations
13.
Li, Hongjie, Xin Zhao, Chunxiang Li, et al.. (2011). Genetic characteristics and migration history of a bronze culture population in the West Liao-River valley revealed by ancient DNA. Journal of Human Genetics. 56(12). 815–822. 22 indexed citations
14.
Si, Dayong, Ying Wang, Yingjie Guo, et al.. (2008). Mechanism of CYP2C9 Inhibition by Flavones and Flavonols. Drug Metabolism and Disposition. 37(3). 629–634. 125 indexed citations
15.
Zhang, Yifan, Dayong Si, Xiaoyan Chen, et al.. (2007). Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects. British Journal of Clinical Pharmacology. 64(1). 67–74. 49 indexed citations
16.
Zheng, Qing‐Chuan, Yahong Zhang, Miao Sun, et al.. (2006). On the human CYP2C9*13 variant activity reduction: a molecular dynamics simulation and docking study. Biochimie. 88(10). 1457–1465. 28 indexed citations
17.
Guo, Yingjie, Ying Wang, Xiaoyan Chen, et al.. (2005). ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS. Drug Metabolism and Disposition. 33(6). 749–753. 60 indexed citations
18.
Guo, Yingjie, et al.. (2005). Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13. Xenobiotica. 35(9). 853–861. 42 indexed citations
19.
Zhong, Dafang, et al.. (2004). Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype. British Journal of Clinical Pharmacology. 59(1). 14–17. 47 indexed citations
20.
Si, Dayong, et al.. (2004). Identification of a novel variant CYP2C9 allele in Chinese. Pharmacogenetics. 14(7). 465–469. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chitra Sridar Breakdown of academic impact, for papers by Stephanie D. Turner Breakdown of academic impact, for papers by Daniel R. Mudra Breakdown of academic impact, for papers by Claire Belloc Breakdown of academic impact, for papers by Brian R. Baer Breakdown of academic impact, for papers by Mika Kurkela Breakdown of academic impact, for papers by Bok-Ryang Kim Breakdown of academic impact, for papers by Susumu Imaoka Breakdown of academic impact, for papers by Martine Bourrié Breakdown of academic impact, for papers by Marc Bertrand
Rankless by CCL
2026